Novo gets the green light for once-daily haemophilia drug following setbacks
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
AstraZeneca’s Tagrisso gains EC approval for NSCLC treatment
RAPT Therapeutics and Shanghai Jemincare sign anti-IgE antibody agreement
SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines
AstraZeneca, Daiichi Sankyo withdraw EU application for lung cancer treatment
XBiotech halts all rheumatology research after missing Phase II endpoints
Analysis
View More
Themes
View MoreEli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Eli Lilly’s investment is seen as an opportunity to drive economic growth for the UK while improving public health.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Novo Nordisk invests $1.2bn in new Denmark facility
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
Vifor Pharma offers £23m to NHS to resolve CMA investigation